In Germany alone, sudden cardiac death causes approximately 80,000 to 100,000 deaths annually. Long-term ECG examinations of patients who have died of sudden cardiac death have shown that ventricular tachycardia and ventricular fibrillation are the most common arrhythmias.
The risk of sudden cardiac death is particularly high in heart failure with severe limitation of the ejection fraction of the left ventricle. However, there are clinical situations where the risk of sudden cardiac death is significantly increased but defibrillator implantation is not yet recommended. These include above all scenarios in which the patient suffers a temporary heart failure in the course of cardiomyopathy, an acute myocardial infarction or acute myocarditis, which can then recover under pharmacological therapy.
Within the framework of the project applied for, a miniaturized body-portable, automatic, external defibrillator (MiniDefi) is to be developed. This represents a treatment option for high-risk patients who would otherwise have to be monitored in hospital. In an emergency, patients and first aiders can be supported directly on site by telemedical assistance from the approaching ambulance. In addition to acute defibrillation, MiniDefi offers telemedicine monitoring and early detection of life-threatening complications, which provides additional protection in the home environment as well as improved quality of life and a greater sense of safety for patients.
M. Ahmad, J. Glitza, F. Müller-von-Aschwege, A. Hein and B. Cauchi; 0Oktober / 2020
Nils Reiss, Thomas Schmidt, Jan-Dirk Hoffmann, Steffen Kunzendorf, Georg Luegmair, Tobias Tröger, Christian Buj, Frerk Müller-von Aschwege; Studies in health technology and informatics; 06 / 2020